3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
5
Observational
1
Sponsor
Cancer Type
Lymphoid
23
Other hematologic neoplasm
11
Myeloid
9
Dermatologic
8
Plasma cell
7
Sarcoma
4
Classical hematology
4
CNS
3
Other neoplasm
2
Thoracic
1
NET
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Colorectal Neoplasms
1328
Carcinoma, Hepatocellular
782
Stomach Neoplasms
720
Pancreatic Neoplasms
701
Colonic Neoplasms
533
Rectal Neoplasms
472
Esophageal Neoplasms
422
Liver Neoplasms
320
Neoplasms
264
Breast Neoplasms
221
Lung Neoplasms
188
Gastrointestinal Neoplasms
164
Cholangiocarcinoma
150
Barrett Esophagus
116
Prostatic Neoplasms
107
Neoplasm Metastasis
105
Ovarian Neoplasms
89
Carcinoma, Non-Small-Cell Lung
80
Anus Neoplasms
77
Melanoma
72
Esophageal Squamous Cell Carcinoma
71
Disease
71
Head and Neck Neoplasms
70
Colorectal Neoplasms, Hereditary Nonpolyposis
67
Biliary Tract Neoplasms
67
Gastrointestinal Stromal Tumors
66
Liver Cirrhosis
60
Gallbladder Neoplasms
58
Recurrence
57
Uterine Cervical Neoplasms
56
Interventions
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lymphoproliferative Disorders
×
Gastrointestinal
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled